Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-909-9 | CAS number: 597-82-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Neurotoxicity
Administrative data
Description of key information
No indication of organophophorus induced delayed neurotoxicity was seen in hens treated with 30 mg/kg bw/day of the test substance.
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Link to relevant study records
- Endpoint:
- neurotoxicity: sub-chronic oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 419 (Delayed Neurotoxicity of Organophosphorus Substances: 28-Day Repeated Dose Study)
- Deviations:
- yes
- Remarks:
- (90 days of exposure as opposed to 28 days, dosing frequency only 5 days/week, only one concentration tested)
- GLP compliance:
- not specified
- Limit test:
- yes
- Specific details on test material used for the study:
- - Name as cited in the publication: Triphenylphosphorothionate (TPPT)
- Purity: 100% - Species:
- hen
- Strain:
- other: Leghorn
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Seaboard, Inc (Roanoke, VA)
- Age at study initiation: at least 1 yr
- Weight at study initiation: 1.1-1.8 kg
- Housing: 4 per cage (2 x 2x 2 ft)
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS: no data - Route of administration:
- oral: gavage
- Vehicle:
- other: synthetic polyol based engine oil
- Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 13 wks
- Frequency of treatment:
- once daily, 5 times per week
- Dose / conc.:
- 30 mg/kg bw/day (nominal)
- Remarks:
- polyol based lubricating oil containing the 3% of TPPT was administered at a dose of 1 g/kg bw (1.02 mL/kg bw) = 30 mg TPPT/kg bw
- No. of animals per sex per dose:
- 17-20
- Control animals:
- other: yes (saline)
- Details on study design:
- - Dose selection rationale: based on the EPA guidelines for delayed neurotoxicity of organophosphorus substances
- Observations and clinical examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
- Cage side observations checked: signs of behavioural changes or physical changes. e.g mobility scores (according to Cavenagh 1954) were assigned based on the abilities of the hens to move around the cage. 0 = normal; 8 = paralysed
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: twice weekly
- Parameter checked: ataxia (the ability to climb an inclined walkway (3 ft, 20°) was used as measure). Scoring using an 8 point scale was used (0 = normal; 8 = paralysed).
BODY WEIGHT: Yes
- Time schedule for examinations: once a week - Specific biochemical examinations:
- NEUROPATHY TARGET ESTERASE (NTE) ACTIVITY AND CHOLINESTERASE ACTIVITY: Yes
- Time schedule for examinations: after 6 weeks and 13 weeks of dosing
- How many animals: 4
- Method of sample collection and processing: no data
- Tissues used: brain and spinal cord
- Animals fasted: no data
- Description of methodology for NTE determination: as described in Sprague et al 1981 (J. Toxicol. Environ. Health 8, 507-518)
- Description of methodology for AChE activity determination: as described in Ellman et al 1961 (Biochem. Pharmacol. 1, 88-95) - Sacrifice and (histo)pathology:
- - Time point of sacrifice: at termination, with heparin (1000 U/ml) and sodium pentobarbital
- Number of animals sacrificed: all animals
- Parameters measured: no data
- Brain weight: no data
- Length and width of brain: no data
- Procedures for perfusion: with room temperature 5% glutaldehyde in 0.1 M phosphate buffer, pH 7.4
- Number of animals perfused: all animals at termination
- Tissues evaluated: brain (forebrain, cerebellum, pons), spinal cord (cervical, thoracic, lumbar), sciatic nerve segment and tibial nerve branch
- Methodology of preparation of sections: no data
- Embedding media: Epoxy and paraffin embedding
- Type of staining: toluidine blue - safranin (epoxy embedded tissue), hematoxylin and eosin (paraffin embedded tissues)
- Thickness: 1 µm (epoxy embedded tissues), 8 µm (paraffin embedded tissues)
- Number of sections: no data
- Number of animals evaluated from each sex and treatment group: no data
OTHER
- Scoring of sections was semi-quantitative and based upon the intensity of degenerating myelinated fibers. Degeneration changes were graded according to a severity scale ranging from 1 - 4
- Scoring was performed blinded - Positive control:
- - Name: TOCP (tri- ortho-tolyl phosphate), administered by gavage in corn oil
- Dose 1: 7.5 mg/kg bw given once a day, 5 days/week for 13 weeks
- Dose 2: 500 mg/kg bw given once, 12 days before the end of the study - Statistics:
- Analysis of variance was used to compare differences among groups, followed, if indicated by Duncan's test with p < 0.05 considered statistically significant.
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Symptoms indicative of delayed neurotoxicity were not observed in the hens treated with the test susbstance. Mean scores obtained from cage side observations and the inclined walkway did not indicate the presence of ataxia or difficulties in standing and or walking in the treated birds. In contrast the positive control substance induced the expected responses; with a statistically significant (p < 0.05) increase in the mean cage side scores 39 days into the study. A statistically significant (p < 0.05) difference in the ability to climb the inclined walkway was also noted on day 88 in the positive control group.
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- Necropsy and neuropathology was performed on all animals that died. Mortality was judged as not directly related with the administration of the jet oil. A variety of avian diseases were identified as being causal for death.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- Body weights were not adversely affected over the 13 week dosing period. There was no statistical significant difference between the negative control (saline), positive control and the test formulation. Although the mean body weight of the positive control was less at week 13 than in week 1, this decrease was not statistically significant.
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- - NTE activity: While NTE activity was not influenced after 6 weeks, the test substance caused a statistically significant (p< 0.05) inhibition of NTE activities after 13 weeks compared to the saline controls (22.6 % in the brain and 17.5 % in the spinal cord). Although for subchronic studies, the threshold generally considered necessary for the induction of organophosphate induced delayed neurotoxicity (OPIDN) has not been delineated, the level of brain NTE inhibition is well below the threshold of 70 % inhibition necessary for the induction of OPIDN in hens following acute dosing (Johnson 1982, Rev. Biochem. Toxicol. 4, 141-212; Johnson 1990, Toxicol. Appl. Pharmacol. 102, 385 -399). For subchronic studies, this threshold has been suggested by Johnson (1990) to lie in the range of 45 - 65%). The findings of the NTE assay are in line with the lack of neuropathological lesions in hens treated with the test substance. The positive control TOCP induced the expected response. NTE activity in TOCP treated hens was significantly (p < 0.05) reduced both at the 6 week as well as the 12 week sacrifice compared to controls. The inhibition was stronger at 13 weeks both in the brain (76 %) and spinal cord (50 %) than at 6 weeks (50 and 43 %, respectively).
- AChE activity: No test substance dependent effect was detected. The positive control substance also did not inhibit AChE activity either. Neither after 6 weeks nor after 13 weeks. This is an appropriate response because it permits the study of OPIDN without confounding effects of cholinergic poisoning. - Neuropathological findings:
- no effects observed
- Description (incidence and severity):
- Microscopic examination of the central and peripheral nervous system of hens treated with the test substance did not reveal lesions characteristic of OPIDN. The positive control substance (TOCP) in contrast caused pathological changes consistent with OPIDN in all birds. Bilateral degeneration of the myelinated nerve fibres was the most conspicuous finding. This effect was observed in both the peripheral and the central nervous systems and was associated in the CNS with signs of gliosis. CNS lesions were seen in the lumbar levels of the medial pontine spinal and rostral (cervical) levels of the spinocerebellar tracts and fasciculus gracilis. These lesions consisted of dense-staining collapsed myelinated axons with associated myelin-rich masses. In addition, some myelinated fibers had swollen, edematous and/or debris-laden axons. A striking feature was the association of gliosis with these neuropathic events. The peripheral nerve lesions (tibial nerve branch) consisted of various stages of Wallerian like degeneration. The peripheral nerve lesions were present in all positive controls but none in any the hens treated with the test substance.
- Dose descriptor:
- NOAEL
- Effect level:
- 30 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: Only dose tested
- Remarks on result:
- other:
- Critical effects observed:
- no
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 30 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- hen
- Quality of whole database:
- A published study comparable to OECD TG 419 with acceptable restrictions is available (Klimisch score: 2).
In addition, a published in vitro study is considered (Klimisch score: 2).
Effect on neurotoxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Effect on neurotoxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Neurotoxicity
In an in vivo study comparable to OECD guideline 419, 17 – 20 hens were treated with synthetic polyol based engine oil containing 3% of the test substance. This corresponds to a dose of 30 mg/kg bw/day. The hens were treated once daily, 5 days per week for the duration of 90 days via gavage. Control hens received saline solution. Tri-ortho-tolyl phosphate, administered by gavage in corn oil was included as the positive control.
Besides cage side and detailed clinical observations, body weights of the treated animals were also monitored. In addition, to appraise organophosphate induced delayed neurotoxicity (OPIDN), the activities of two enzymes were determined, i.e. neuropathy target esterase (NTE) and cholinesterase (AChE) isolated from brain (forebrain, cerebellum, pons) and spinal cord (cervical, thoracic, lumbar); measurements conducted after 6 and 13 weeks of dosing. Histopathological observations were performed in the following tissues: brain (forebrain, cerebellum, pons), spinal cord (cervical, thoracic, lumbar), sciatic nerve segment and tibial nerve branch.
Mortality and body weights were not influenced. Clinical symptoms indicative of delayed neurotoxicity were not observed in the hens treated with the test substance. Mean scores obtained from cage side observations and the inclined walkway did not indicate the presence of ataxia or difficulties in standing and or walking in the treated birds. In contrast the positive control substance induced the expected responses; with a statistically significant (p < 0.05) increase in the mean cage side scores 39 days through the study. A statistically significant (p < 0.05) difference in the ability to climb the inclined walkway was also noted on day 88 in the positive control group.
While NTE activity was not influenced after 6 weeks, the test substance caused a statistically significant (p< 0.05) inhibition of NTE activities after 13 weeks compared to the saline controls (22.6 % in the brain and 17.5 % in the spinal cord). Although for sub-chronic studies, the threshold generally considered necessary for the induction of organophosphate induced delayed neurotoxicity (OPIDN) has not been delineated, the level of brain NTE inhibition is well below the threshold of 70 % inhibition necessary for the induction of OPIDN in hens following acute dosing (Johnson 1982, Rev. Biochem. Toxicol. 4: 141-212; Johnson 1990, Toxicol. Appl. Pharmacol. 102: 385 -399). For sub-chronic studies, this threshold has been suggested by Johnson (1990) to lie in the range of 45 - 65%. The findings of the NTE assay are in line with the lack of histopatholocigal findings in the respective tissues in hens treated with the test substance. Microscopic examination of the central and peripheral nervous system of hens treated with the test substance did not reveal lesions characteristic of OPIDN. Hence the NOAEL for neurotoxicity in hen is 30 mg/kg bw/day.
The positive control TOCP induced the expected response. NTE activity in TOCP treated hens was significantly (p < 0.05) reduced both at the 6 week as well as the 13 week sacrifice compared to controls. The inhibition was stronger at 13 weeks both in the brain (76 %) and spinal cord (50 %) than at 6 weeks (50 and 43 %, respectively). The positive control substance (TOCP) caused pathological changes consistent with OPIDN in all birds as detected via microscopic examination.
No test substance dependent effect on AChE activity was detected in treated hens (Daughtrey W et al. 1996). In support of this finding are data from an in vitro cholinesterase assay which indicated no inhibitory effect of the test substance on AChE activity after treatment in vitro with concentrations ranging from 39.06 to 5,000 µg/mL.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for the purpose of classification. Based on the criteria laid down in Regulation (EC) No.1272/2008, classification for neurotoxicity is not warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.